Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-033066
Filing Date
2025-03-05
Accepted
2025-03-05 07:06:39
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K itos-20241231.htm   iXBRL 10-K 3246859
2 EX-10.15 itos-ex10_15.htm EX-10.15 136529
3 EX-19.1 itos-ex19_1.htm EX-19.1 116480
4 EX-21.1 itos-ex21_1.htm EX-21.1 9349
5 EX-23.1 itos-ex23_1.htm EX-23.1 3697
6 EX-31.1 itos-ex31_1.htm EX-31.1 17118
7 EX-31.2 itos-ex31_2.htm EX-31.2 17164
8 EX-32.1 itos-ex32_1.htm EX-32.1 11048
9 EX-32.2 itos-ex32_2.htm EX-32.2 11904
10 GRAPHIC img165113085_0.jpg GRAPHIC 350182
11 GRAPHIC img165113085_1.jpg GRAPHIC 1539553
12 GRAPHIC img165113085_2.jpg GRAPHIC 1625328
13 GRAPHIC img165113085_3.jpg GRAPHIC 2368161
14 GRAPHIC img165113085_4.jpg GRAPHIC 234364
  Complete submission text file 0000950170-25-033066.txt   28874504

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itos-20241231.xsd EX-101.SCH 1730756
97 EXTRACTED XBRL INSTANCE DOCUMENT itos-20241231_htm.xml XML 2277630
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39401 | Film No.: 25708803
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)